<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35510863</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Neddylation of Enterovirus 71 VP2 Protein Reduces Its Stability and Restricts Viral Replication.</ArticleTitle><Pagination><StartPage>e0059822</StartPage><MedlinePgn>e0059822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00598-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00598-22</ELocationID><Abstract><AbstractText>Posttranslational modifications (PTMs) of viral proteins play critical roles in virus infection. The role of neddylation in enterovirus 71 (EV71) replication remains poorly defined. Here, we showed that the structural protein VP2 of EV71 can be modified by neural precursor cell-expressed developmentally downregulated protein 8 (NEDD8) in an E3 ligase X-linked inhibitor of apoptosis protein (XIAP)-dependent manner. Mutagenesis and biochemical analyses mapped the neddylation site at lysine 69 (K69) of VP2 and demonstrated that neddylation reduced the stability of VP2. In agreement with the essential role of VP2 in viral replication, studies with EV71 reporter viruses with wild-type VP2 (enhanced green fluorescent protein [EGFP]-EV71) and a K69R mutant VP2 (EGFP-EV71-VP2 K69R) showed that abolishment of VP2 neddylation increased EV71 replication. In support of this finding, overexpression of NEDD8 significantly inhibited the replication of wild-type EV71 and EGFP-EV71, but not EGFP-EV71-VP2 K69R, whereas pharmacologic inhibition of neddylation with the NEDD8-activating enzyme inhibitor MLN4924 promoted the replication of EV71 in biologically relevant cell types. Our results thus support the notion that EV71 replication can be negatively regulated by host cellular and pathobiological cues through neddylation of VP2 protein. <b>IMPORTANCE</b> Neddylation is a ubiquitin-like posttranslational modification by conjugation of neural precursor cell-expressed developmentally downregulated protein 8 (NEDD8) to specific proteins for regulation of their metabolism and biological activities. In this study, we demonstrated for the first time that EV71 VP2 protein is neddylated at K69 residue to promote viral protein degradation and consequentially suppress multiplication of the virus. Our findings advance knowledge related to the roles of VP2 in EV71 virulence and the neddylation pathway in the host restriction of EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Boming</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3725-3258</Identifier><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075687">NEDD8 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C082860">NEDD8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051636">X-Linked Inhibitor of Apoptosis Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496866">XIAP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="Y">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075687" MajorTopicYN="N">NEDD8 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051636" MajorTopicYN="N">X-Linked Inhibitor of Apoptosis Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">MLN4924</Keyword><Keyword MajorTopicYN="N">VP2</Keyword><Keyword MajorTopicYN="N">XIAP</Keyword><Keyword MajorTopicYN="N">neddylation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>5</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35510863</ArticleId><ArticleId IdType="pmc">PMC9131864</ArticleId><ArticleId IdType="doi">10.1128/jvi.00598-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn PC. 2012. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2:199&#x2013;205. 10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Li YH. 2019. Recent progress on functional genomics research of enterovirus 71. Virol Sin 34:9&#x2013;21. 10.1007/s12250-018-0071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P. 2003. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 9:461&#x2013;468. 10.3201/eid0904.020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0904.020395</ArticleId><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC. 2003. Formation of enteroviruslike particle aggregates by recombinant baculoviruses coexpressing P1 and 3CD in insect cells. Biotechnol Lett 25:919&#x2013;925. 10.1023/A:1024071514438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1024071514438</ArticleId><ArticleId IdType="pubmed">12889824</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VT, Kwang J. 2012. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J 9:55. 10.1186/1743-422X-9-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-55</ArticleId><ArticleId IdType="pmc">PMC3307493</ArticleId><ArticleId IdType="pubmed">22361222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou DM, Zhao YG, Kotecha A, Fry EE, Kelly JT, Wang XX, Rao ZH, Rowlands DJ, Ren JS, Stuart DI. 2019. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol 4:414&#x2013;419. 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. 2012. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422:132&#x2013;143. 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Mehta D, Mishra N, Nayak D, Sunil S. 2020. Role of host-mediated post-translational modifications (PTMs) in RNA virus pathogenesis. Int J Mol Sci 22:323. 10.3390/ijms22010323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010323</ArticleId><ArticleId IdType="pmc">PMC7796338</ArticleId><ArticleId IdType="pubmed">33396899</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zheng ZH, Shu B, Meng J, Zhang Y, Zheng CS, Ke XL, Gong P, Hu QX, Wang HZ. 2016. SUMO modification stabilizes enterovirus 71 polymerase 3D to facilitate viral replication. J Virol 90:10472&#x2013;10485. 10.1128/JVI.01756-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z, Zhuo Y, Tan XY, Zhou Z, Yuan JG, Qiang BQ, Yan JH, Peng XZ, Gao GF. 2006. SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. J Med Virol 78:1365&#x2013;1373. 10.1002/jmv.20707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20707</ArticleId><ArticleId IdType="pmc">PMC7167196</ArticleId><ArticleId IdType="pubmed">16998888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharaj P, Atkins C, Luthra P, Giraldo MI, Dawes BE, Miorin L, Johnson JR, Krogan NJ, Basler CF, Freiberg AN, Rajsbaum R. 2017. The host E3-ubiquitin ligase TRIM6 ubiquitinates the Ebola virus VP35 protein and promotes virus replication. J Virol 91:e00833-17. 10.1128/JVI.00833-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00833-17</ArticleId><ArticleId IdType="pmc">PMC5571272</ArticleId><ArticleId IdType="pubmed">28679761</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim M, Biquand E, Declercq M, Jacob Y, van der Werf S, Demeret C. 2020. Nonproteolytic K29-linked ubiquitination of the PB2 replication protein of influenza A viruses by proviral cullin 4-based E3 ligases. mBio 11:e00305-20. 10.1128/mBio.00305-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00305-20</ArticleId><ArticleId IdType="pmc">PMC7157767</ArticleId><ArticleId IdType="pubmed">32265326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Barouch-Bentov R, Xiao F, Schor S, Pu S, Biquand E, Lu A, Lindenbach BD, Jacob Y, Demeret C, Einav S. 2019. MARCH8 ubiquitinates the hepatitis C virus nonstructural 2 protein and mediates viral envelopment. Cell Rep 26:1800&#x2013;1814.e5. 10.1016/j.celrep.2019.01.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.075</ArticleId><ArticleId IdType="pmc">PMC7053169</ArticleId><ArticleId IdType="pubmed">30759391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali H, Mano M, Braga L, Naseem A, Marini B, Vu DM, Collesi C, Meroni G, Lusic M, Giacca M. 2019. Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation. Nat Commun 10:926. 10.1038/s41467-019-08810-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08810-0</ArticleId><ArticleId IdType="pmc">PMC6389893</ArticleId><ArticleId IdType="pubmed">30804369</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T, Fukuda K, Abe K, Sato S, Fukasawa M, Yamakawa Y, Nishijima M, Moriishi K, Matsuura Y, Wakita T, Suzuki T, Howley PM, Miyamura T, Shoji I. 2007. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 81:1174&#x2013;1185. 10.1128/JVI.01684-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01684-06</ArticleId><ArticleId IdType="pmc">PMC1797542</ArticleId><ArticleId IdType="pubmed">17108031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurer C, Berthoux L, Luban J. 2005. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol 79:910&#x2013;917. 10.1128/JVI.79.2.910-917.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.910-917.2005</ArticleId><ArticleId IdType="pmc">PMC538558</ArticleId><ArticleId IdType="pubmed">15613319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamborlini A, Coiffic A, Beauclair G, Delelis O, Paris J, Koh Y, Magne F, Giron ML, Tobaly-Tapiero J, Deprez E, Emiliani S, Engelman A, de Th&#xe9; H, Sa&#xef;b A. 2011. Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect. J Biol Chem 286:21013&#x2013;21022. 10.1074/jbc.M110.189274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.189274</ArticleId><ArticleId IdType="pmc">PMC3121452</ArticleId><ArticleId IdType="pubmed">21454548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang LY, Wang YW, Chen YC, Weng KF, Shih SR, Shih HM. 2011. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J Biol Chem 286:31373&#x2013;31384. 10.1074/jbc.M111.254896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.254896</ArticleId><ArticleId IdType="pmc">PMC3173077</ArticleId><ArticleId IdType="pubmed">21784861</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Veen AG, Ploegh HL. 2012. Ubiquitin-like proteins. Annu Rev Biochem 81:323&#x2013;357. 10.1146/annurev-biochem-093010-153308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-093010-153308</ArticleId><ArticleId IdType="pubmed">22404627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponts N, Yang JF, Chung DW, Prudhomme J, Girke T, Horrocks P, Le Roch KG. 2008. Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS One 3:e2386. 10.1371/journal.pone.0002386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002386</ArticleId><ArticleId IdType="pmc">PMC2408969</ArticleId><ArticleId IdType="pubmed">18545708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Zhang W, Sun Y, Jia L. 2018. Protein neddylation and its alterations in human cancers for targeted therapy. Cell Signal 44:92&#x2013;102. 10.1016/j.cellsig.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2018.01.009</ArticleId><ArticleId IdType="pmc">PMC5829022</ArticleId><ArticleId IdType="pubmed">29331584</ArticleId></ArticleIdList></Reference><Reference><Citation>Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Jr, Holton JM, Schulman BA. 2003. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol Cell 12:1427&#x2013;1437. 10.1016/S1097-2765(03)00452-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(03)00452-0</ArticleId><ArticleId IdType="pubmed">14690597</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA. 2005. Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8&#x2019;s E1. Mol Cell 17:341&#x2013;350. 10.1016/j.molcel.2004.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.12.020</ArticleId><ArticleId IdType="pubmed">15694336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L, Yeh ET. 1999. Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem 274:12036&#x2013;12042. 10.1074/jbc.274.17.12036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.17.12036</ArticleId><ArticleId IdType="pubmed">10207026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Morgan MA, Sun Y. 2014. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Antioxid Redox Signal 21:2383&#x2013;2400. 10.1089/ars.2013.5795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5795</ArticleId><ArticleId IdType="pmc">PMC4241876</ArticleId><ArticleId IdType="pubmed">24410571</ArticleId></ArticleIdList></Reference><Reference><Citation>Enchev RI, Schulman BA, Peter M. 2015. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol 16:30&#x2013;44. 10.1038/nrm3919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3919</ArticleId><ArticleId IdType="pmc">PMC5131867</ArticleId><ArticleId IdType="pubmed">25531226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwechheimer C. 2018. NEDD8-its role in the regulation of Cullin-RING ligases. Curr Opin Plant Biol 45:112&#x2013;119. 10.1016/j.pbi.2018.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbi.2018.05.017</ArticleId><ArticleId IdType="pubmed">29909289</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayasimha K, Dolan BP. 2021. The many potential fates of non-canonical protein substrates subject to NEDDylation. Cells 10:2660. 10.3390/cells10102660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102660</ArticleId><ArticleId IdType="pmc">PMC8534235</ArticleId><ArticleId IdType="pubmed">34685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang TH, Ye Z, Yang XH, Qin YJ, Hu Y, Tong XM, Lai WB, Ye X. 2017. Neddylation of PB2 reduces its stability and blocks the replication of influenza A virus. Sci Rep 7:43691. 10.1038/srep43691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43691</ArticleId><ArticleId IdType="pmc">PMC5333077</ArticleId><ArticleId IdType="pubmed">28252002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Chai WJ, Min J, Ye Z, Tong XM, Qi DD, Liu WJ, Luo EJ, Li J, Ye X. 2020. Neddylation of M1 negatively regulates the replication of influenza A virus. J Gen Virol 101:1242&#x2013;1250. 10.1099/jgv.0.001503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001503</ArticleId><ArticleId IdType="pubmed">33016861</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu NN, Zhang JF, Yang XH, Jiao T, Zhao X, Li WX, Zhu JH, Yang P, Jin JP, Peng JR, Li ZW, Ye X. 2017. HDM2 promotes neddylation of hepatitis B virus HBx to enhance its stability and function. J Virol 91:e00340-17. 10.1128/JVI.00340-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00340-17</ArticleId><ArticleId IdType="pmc">PMC5533936</ArticleId><ArticleId IdType="pubmed">28592528</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie MJ, Guo HT, Lou GH, Yao JP, Liu YN, Sun Y, Yang ZG, Zheng M. 2021. Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1&#x3b1;-C/EBP&#x3b1;-HNF4&#x3b1; axis. J Cell Mol Med 25:840&#x2013;854. 10.1111/jcmm.16137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16137</ArticleId><ArticleId IdType="pmc">PMC7812279</ArticleId><ArticleId IdType="pubmed">33263949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XY, Ye ZJ, Pei YJ, Qiu GH, Wang QY, Xu YL, Shen BF, Zhang JY. 2016. Neddylation is required for herpes simplex virus type I (HSV-1)-induced early phase interferon-beta production. Cell Mol Immunol 13:578&#x2013;583. 10.1038/cmi.2015.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2015.35</ArticleId><ArticleId IdType="pmc">PMC5037273</ArticleId><ArticleId IdType="pubmed">27593482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekorchuk MD, Sharifi HJ, Furuya AK, Jellinger R, de Noronha CM. 2013. HIV relies on neddylation for ubiquitin ligase-mediated functions. Retrovirology 10:138. 10.1186/1742-4690-10-138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-10-138</ArticleId><ArticleId IdType="pmc">PMC3842660</ArticleId><ArticleId IdType="pubmed">24245672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Sun Y. 2020. Neddylation-independent activities of MLN4924. Adv Exp Med Biol 1217:363&#x2013;372. 10.1007/978-981-15-1025-0_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-1025-0_21</ArticleId><ArticleId IdType="pubmed">31898238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann H, Norton TD, Schultz ML, Polsky SB, Sunseri N, Landau NR. 2013. Inhibition of CUL4A neddylation causes a reversible block to SAMHD1-mediated restriction of HIV-1. J Virol 87:11741&#x2013;11750. 10.1128/JVI.02002-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02002-13</ArticleId><ArticleId IdType="pmc">PMC3807335</ArticleId><ArticleId IdType="pubmed">23986575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambagala AP, Solheim JC, Srikumaran S. 2005. Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet Immunol Immunopathol 107:1&#x2013;15. 10.1016/j.vetimm.2005.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2005.04.006</ArticleId><ArticleId IdType="pubmed">15978672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinaud S, Consiglieri G, Bouziat R, Urrutia A, Graff-Dubois S, Fourati S, Malet I, Guergnon J, Guihot A, Katlama C, Autran B, van Endert P, Lemonnier FA, Appay V, Schwartz O, Kloetzel PM, Moris A. 2011. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. PLoS Pathog 7:e1002049. 10.1371/journal.ppat.1002049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002049</ArticleId><ArticleId IdType="pmc">PMC3093368</ArticleId><ArticleId IdType="pubmed">21589903</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DJ, Lenschow DJ. 2013. The antiviral activities of ISG15. J Mol Biol 425:4995&#x2013;5008. 10.1016/j.jmb.2013.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.09.041</ArticleId><ArticleId IdType="pmc">PMC4090058</ArticleId><ArticleId IdType="pubmed">24095857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Guo HR, Wang J, Li Y, Gao YH, Liu Q, Niu JQ, Wei W. 2021. Inhibition of the neddylation pathway suppresses enterovirus replication. Virol Sin 36:1664&#x2013;1667. 10.1007/s12250-021-00427-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00427-2</ArticleId><ArticleId IdType="pmc">PMC8692535</ArticleId><ArticleId IdType="pubmed">34351571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Zhong M, Li YP, Li K, Wu S, Guo TT, Cen S, Jiang JD, Li ZR, Li YH. 2019. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity. Antiviral Res 165:23&#x2013;33. 10.1016/j.antiviral.2019.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.03.005</ArticleId><ArticleId IdType="pubmed">30862444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Mar KB, Sari L, Gaszek IK, Cheng Q, Evers BM, Shelton JM, Wight-Carter M, Siegwart DJ, Lin MM, Schoggins JW. 2021. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184:3410&#x2013;3425.e17. 10.1016/j.cell.2021.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Epidemiol 27:493&#x2013;497. 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>